Skip to content

Difference in baseline risk assessment of postoperative recurrence between physicians and patients.

Difference in baseline risk assessment of postoperative recurrence between physicians and patients. - Difference in baseline risk assessment between physicians and patients.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000028699
Enrollment
260
Registered
2017-08-17
Start date
2017-07-31
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary invasive breast cancer

Interventions

None listed

Sponsors

Aichi Cancer Center Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who underwent surgery for primary invasive breast cancer at Aichi Cancer Center Hospital.

Exclusion criteria

Exclusion criteria: 1. Patients with noninvasive cancer. 2. Patients who underwent preoperative adjuvant therapy. 3. Patients who have difficultly trying to understand the concept of baseline risk of recurrence. 4. Patients who the doctor judged unsuitable for this study.

Design outcomes

Primary

MeasureTime frame
Difference in baseline risk assessment by physicians and patients in invasive breast cancer patients.

Secondary

MeasureTime frame
1.Difference in baseline risk assessment by physicians and patients by stage in all subtypes. 2.Difference in baseline risk assessment by physicians and patients by subtype in all stages. 3.Influence of patient's internal factors on difference in baceline risk assessment by physicians and patients.

Countries

Japan

Contacts

Public ContactMakiko Mori

Aichi Cancer Center Hospital Breast Oncology

m.mori@aichi-cc.jp052-762-6111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026